ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells
Cited by 58
Related Papers
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice
|Hepatology|2004|177
<p>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer</p>
|OncoTargets and Therapy|2020|45
Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism
|International Journal of Biological Sciences|2022|32
Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition<i>via</i>nuclear factor-κB signaling in colorectal cancer cells
|World Journal of Gastroenterology|2016|29